The successful use of rifampicin to provide an alternative pathway of vitamin D catabolism has been reported in patients with an impaired function of their CYP24A1, which is linked to idiopathic hypercalcemia, significantly improving serum calcium and hypercalciuria [62]. The gene discussed is CYP24A1; the disease is Hypercalciuria.